Production (Stage)
Palisade Bio, Inc.
PALI
$0.6967
$0.01642.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.79% | -16.69% | -13.02% | 10.54% | -5.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.11% | 15.47% | -4.90% | 16.68% | 32.17% |
| Operating Income | 37.11% | -15.47% | 4.90% | -16.68% | -45.24% |
| Income Before Tax | 36.77% | -12.55% | 3.03% | -20.25% | -50.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.77% | -12.55% | 3.03% | -20.25% | -50.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.77% | -12.55% | 3.03% | -20.25% | -50.73% |
| EBIT | 37.11% | -15.47% | 4.90% | -16.68% | -45.24% |
| EBITDA | 37.12% | -15.47% | 4.90% | -16.72% | -45.25% |
| EPS Basic | 89.87% | 67.82% | 68.50% | 58.12% | 43.55% |
| Normalized Basic EPS | 89.87% | 65.18% | 68.36% | 58.12% | 43.55% |
| EPS Diluted | 89.87% | 67.82% | 68.50% | 58.12% | 43.55% |
| Normalized Diluted EPS | 89.87% | 65.18% | 68.36% | 58.12% | 43.55% |
| Average Basic Shares Outstanding | 524.35% | 249.81% | 206.45% | 187.10% | 166.98% |
| Average Diluted Shares Outstanding | 524.35% | 249.81% | 206.45% | 187.10% | 166.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |